跳至主要内容
临床试验/JPRN-UMIN000020763
JPRN-UMIN000020763已完成未知

A study on the effect of powdered tea on postprandial hyperglycemia- A randomized, double-blind, placebo-controlled, cross-over trial

KSO Corporation0 个研究点目标入组 50 人开始时间: 2016年1月29日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 65years-old(—)
性别
All

入选标准

  • 1) Males and females from 20 to 64 years age
  • 2) Subjects whose fasting plasma glucose levels are from 110 to 125 mg/dl or whose 75g-oral glucose tolerance test (OGTT) 2 hour glucose levels are from 140 to 199 mg/dl
  • 3) Not heavy alcoholic drinker. (Subjects who can stop drinking from 2 days before each measurement.)
  • 4) Subjects who can make self-judgment and are voluntarily giving written informed consent

排除标准

  • 1) Subjects who use oral medication affecting blood glucose
  • 2) Subjects who constantly consume supplements and/or functional foods (including Food for Specified Health Uses) affecting blood glucose
  • 3) Subjects who have declared allergic reaction to ingredients contained in powdered tea, placebo or high-carbohydrate diet
  • 4) Subjects who need medical treatment for diabetes
  • 5) Subjects who contract or are under treatment or are medical history for serious diseases (e.g., liver disease, kidney disease, and/or heart disease), thyroid gland disease, adrenal gland disease, and/or metabolic disorder
  • 6) Subjects who have a chronic disease and use medicines continuously
  • 7) Subjects who have a history of digestive disease affecting digestion and absorption
  • 8) Subjects whose blood glucose level measured by simple analyzer is more than 150 mg/dl
  • 9) Subjects who are judged as unsuitable for the study based on the results of blood tests by the investigator
  • 10) Subjects who have donated over 200 ml of blood and/or blood components within the last one month prior to the current study or over 400 ml of blood and/or blood components within the last three months prior to the current study
  • 11) Subjects who are diagnosed as anemic and not suitable for frequent collection of blood
  • 12) Subjects who are under treatment for or have a history of drug addiction and/or alcoholism
  • 13) Subjects who are planning to participate in other clinical studies
  • 14) Subjects who are planning to become pregnant after informed consent for the current study or are pregnant or lactating
  • 15) Subjects who are judged as unsuitable for the study by the investigator for other reasons

研究者

相似试验